<DOC>
	<DOCNO>NCT00909584</DOCNO>
	<brief_summary>This multicenter Phase 2 randomize parallel-group study determine effect Telintra treatment severe chronic neutropenia . Patients randomize Telintra enter observation period option crossover Telintra treatment 1:1 allocation .</brief_summary>
	<brief_title>Study Ezatiostat ( Telintra Tablets ) Treatment Severe Chronic Neutropenia</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<criteria>Confirmed Idiopathic Severe Chronic Neutropenia ECOG performance status 02 Adequate liver renal function Adequate Red Blood Cell Platelet count Prior treatment SCN NonIdiopathic type SCN , ie . cyclic , congenital History chromosomal abnormality , myelodysplasia , hematologic malignancy , aplastic anemia , systemic lupus erythematosus , rheumatoid arthritis ( Felty 's syndrome ) , collagen disease , druginduced neutropenia , autoimmune neutropenia Use granulocyte colony stimulate factor ( GCSF ) , glucocorticoid , gamma globulin , lithium investigational drug ( ) within one month enrollment History bone marrow transplantation stem cell support</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Hematology</keyword>
	<keyword>Neutropenia</keyword>
	<keyword>SCN</keyword>
	<keyword>Severe Chronic Neutropenia</keyword>
	<keyword>Idiopathic</keyword>
	<keyword>Telintra</keyword>
	<keyword>ezatiostat hydrochloride</keyword>
	<keyword>ezatiostat</keyword>
	<keyword>TLK199</keyword>
	<keyword>Glutathione</keyword>
	<keyword>Glutathione analog</keyword>
	<keyword>Glutathione Transferase</keyword>
	<keyword>Glutathione Transferase inhibitor</keyword>
	<keyword>Glutathione Transferase P1-1 inhibitor</keyword>
	<keyword>GSTp1-1 inhibitor</keyword>
	<keyword>Apoptosis</keyword>
	<keyword>Differentiation</keyword>
	<keyword>Enzyme inhibitor</keyword>
</DOC>